256 related articles for article (PubMed ID: 22210352)
21. Selenium-containing thioredoxin reductase inhibitor ethaselen sensitizes non-small cell lung cancer to radiotherapy.
Wang L; Fu JN; Wang JY; Jin CJ; Ren XY; Tan Q; Li J; Yin HW; Xiong K; Wang TY; Liu XM; Zeng HH
Anticancer Drugs; 2011 Sep; 22(8):732-40. PubMed ID: 21562407
[TBL] [Abstract][Full Text] [Related]
22. EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells.
Zou P; Xia Y; Chen W; Chen X; Ying S; Feng Z; Chen T; Ye Q; Wang Z; Qiu C; Yang S; Liang G
Oncotarget; 2016 Apr; 7(14):18050-64. PubMed ID: 26919110
[TBL] [Abstract][Full Text] [Related]
23. Pyrroloquinoline quinone modulates the kinetic parameters of the mammalian selenoprotein thioredoxin reductase 1 and is an inhibitor of glutathione reductase.
Xu J; Arnér ES
Biochem Pharmacol; 2012 Mar; 83(6):815-20. PubMed ID: 22226931
[TBL] [Abstract][Full Text] [Related]
24. Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer.
Zou P; Xia Y; Ji J; Chen W; Zhang J; Chen X; Rajamanickam V; Chen G; Wang Z; Chen L; Wang Y; Yang S; Liang G
Cancer Lett; 2016 May; 375(1):114-126. PubMed ID: 26963494
[TBL] [Abstract][Full Text] [Related]
25. Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity.
Zheng X; Ma W; Sun R; Yin H; Lin F; Liu Y; Xu W; Zeng H
Redox Biol; 2018 Apr; 14():237-249. PubMed ID: 28965082
[TBL] [Abstract][Full Text] [Related]
26. Thiophosphate and selenite conversely modulate cell death induced by glutathione depletion or cisplatin: effects related to activity and Sec contents of thioredoxin reductase.
Peng X; Xu J; Arnér ES
Biochem J; 2012 Oct; 447(1):167-74. PubMed ID: 22784015
[TBL] [Abstract][Full Text] [Related]
27. Why is mammalian thioredoxin reductase 1 so dependent upon the use of selenium?
Lothrop AP; Snider GW; Ruggles EL; Hondal RJ
Biochemistry; 2014 Jan; 53(3):554-65. PubMed ID: 24393022
[TBL] [Abstract][Full Text] [Related]
28. Synergistic inhibition of sunitinib and ethaselen against human colorectal cancer cells proliferation.
Zheng X; Zhang Y; Zhang L; Xu W; Ma W; Sun R; Zeng H
Biomed Pharmacother; 2016 Oct; 83():212-220. PubMed ID: 27372405
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo.
Fan C; Zheng W; Fu X; Li X; Wong YS; Chen T
Cell Death Dis; 2014 Apr; 5(4):e1191. PubMed ID: 24763048
[TBL] [Abstract][Full Text] [Related]
30. Synergistic effect of ethaselen and selenite treatment against A549 human non-small cell lung cancer cells.
Xu W; Ma WW; Zeng HH
Asian Pac J Cancer Prev; 2014; 15(17):7129-35. PubMed ID: 25227802
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial thioredoxin reductase inhibition, selenium status, and Nrf-2 activation are determinant factors modulating the toxicity of mercury compounds.
Branco V; Godinho-Santos A; Gonçalves J; Lu J; Holmgren A; Carvalho C
Free Radic Biol Med; 2014 Aug; 73():95-105. PubMed ID: 24816296
[TBL] [Abstract][Full Text] [Related]
32. Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads.
Kaminska KK; Bertrand HC; Tajima H; Stafford WC; Cheng Q; Chen W; Wells G; Arner ES; Chew EH
Oncotarget; 2016 Jun; 7(26):40233-40251. PubMed ID: 27244886
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of N-acetyl-S-(p-chlorophenylcarbamoyl)cysteine as an irreversible inhibitor of mammalian thioredoxin reductase1.
Chen W; Jiang Z; Lin N; Zheng Z; Chen Z; Zhang X; Guan X
J Enzyme Inhib Med Chem; 2016; 31(2):229-35. PubMed ID: 25778746
[TBL] [Abstract][Full Text] [Related]
34. Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase.
Duan D; Zhang B; Yao J; Liu Y; Sun J; Ge C; Peng S; Fang J
Free Radic Biol Med; 2014 Apr; 69():15-25. PubMed ID: 24407164
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure and catalysis of the selenoprotein thioredoxin reductase 1.
Cheng Q; Sandalova T; Lindqvist Y; Arnér ES
J Biol Chem; 2009 Feb; 284(6):3998-4008. PubMed ID: 19054767
[TBL] [Abstract][Full Text] [Related]
36. APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase.
Peng X; Zhang MQ; Conserva F; Hosny G; Selivanova G; Bykov VJ; Arnér ES; Wiman KG
Cell Death Dis; 2013 Oct; 4(10):e881. PubMed ID: 24157875
[TBL] [Abstract][Full Text] [Related]
37. TrxR1 as a potent regulator of the Nrf2-Keap1 response system.
Cebula M; Schmidt EE; Arnér ES
Antioxid Redox Signal; 2015 Oct; 23(10):823-53. PubMed ID: 26058897
[TBL] [Abstract][Full Text] [Related]
38. The mechanism of apoptosis induced by a novel thioredoxin reductase inhibitor in A549 cells: possible involvement of nuclear factor-kappaB-dependent pathway.
Lan L; Zhao F; Wang Y; Zeng H
Eur J Pharmacol; 2007 Jan; 555(2-3):83-92. PubMed ID: 17116300
[TBL] [Abstract][Full Text] [Related]
39. Identification of phenazine analogue as a novel scaffold for thioredoxin reductase I inhibitors against Hep G2 cancer cell lines.
Liao J; Wang L; Wu Z; Wang Z; Chen J; Zhong Y; Jiang F; Lu Y
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1158-1163. PubMed ID: 31179772
[TBL] [Abstract][Full Text] [Related]
40. Acetylation Regulates Thioredoxin Reductase Oligomerization and Activity.
Wright DE; Altaany Z; Bi Y; Alperstein Z; O'Donoghue P
Antioxid Redox Signal; 2018 Aug; 29(4):377-388. PubMed ID: 29117711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
